Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

Background: Technosphere(®) insulin (TI), an inhaled human insulin with a fast onset of action, provides a novel option for the control of prandial glucose. We used the University of Virginia (UVA)/Padova simulator to explore in-silico the potential benefit of different dosing regimens on postprandi...

Descripción completa

Detalles Bibliográficos
Autores principales: Visentin, Roberto, Giegerich, Clemens, Jäger, Robert, Dahmen, Raphael, Boss, Anders, Grant, Marshall, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035370/
https://www.ncbi.nlm.nih.gov/pubmed/27333446
http://dx.doi.org/10.1089/dia.2016.0128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035370/
https://www.ncbi.nlm.nih.gov/pubmed/27333446
http://dx.doi.org/10.1089/dia.2016.0128

Ejemplares similares